公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2020 | Does antimicrobial therapy affect mortality of patients with carbapenem-resistant Klebsiella pneumoniae bacteriuria? A nationwide multicenter study in Taiwan | Chuang C.; Su C.-F.; Lin J.-C.; Lu P.-L.; Huang C.-T.; JANN-TAY WANG ; Chuang Y.-C.; Kristopher Siu L.; Fung C.-P.; Lin Y.-T. | Microorganisms | 4 | 4 | |
2019 | Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials | Cahn P.; Madero J.S.; Arribas J.R.; Antinori A.; Ortiz R.; Clarke A.E.; CHIEN-CHING HUNG ; Rockstroh J.K.; Girard P.-M.; Sievers J.; Man C.; Currie A.; Underwood M.; Tenorio A.R.; Pappa K.; Wynne B.; Fettiplace A.; Gartland M.; Aboud M.; Smith K.; Cassetti L.; David D.; Figueras L.; Losso M.; Lopardo G.; Lupo S.; Porteiro N.; Sánchez M.; Bloch M.; Cooper D.; Finlayson R.; Kelleher A.; Koh K.; Lewis D.; McMahon J.; Moore R.; Roth N.; Shields M.; De Wit S.; Florence E.; Goffard J.-C.; Demeester R.; Lacor P.; Vandercam B.; Vandekerckhove L.; Angel J.; Baril J.-G.; Conway B.; De Pokomandy A.; Szabo J.; Walmsley S.; Bouchaud O.; Chidiac C.; Delobel P.; Goujard C.; Katlama C.; Molina J.-M.; Pialoux G.; Philibert P.; Bogner J.; Esser S.; Krznaric I.; Lehmann C.; Spinner C.; Stellbrink H.-J.; Stephan C.; Stoehr A.; Barchi E.; Caramello P.; Castelli F.; Cattelan A.M.; D'Arminio Monforte A.; Di Biagio A.; Di Perri G.; Gori A.; Maggiolo F.; Menzaghi B.; Migliorino G.; Mussini C.; Penco G.; Puoti M.; Rizzardini G.; Gulminetti R.; Lazzarin A.; Quirino T.; Sighinolfi L.; Viale P.; Amaya Tapia G.; Andrade Villanueva J.; Granados Reyes E.R.; Perez Rios A.; Santoscoy Gomez M.; Den Hollander J.; Rijnders B.; Hidalgo J.A.; Hercilla Vasquez L.; Illescas L.; Olczak A.; Mansinho K.; Correia Pacheco P.P.; Teófilo E.; Saraiva da Cunha J.; Sarmento e Castro R.; Serrão R.; Arbune M.; Jianu C.; Oprea A.; Preotescu L.; Prisacariu L.-J.; Belonosova E.; Borodkina O.; Chernova O.; Gankina N.; Kizhlo S.; Kulagin V.; Kurina N.; Nagimova F.; Pokrovsky V.; Ryamova E.; Voronin E.; Yakovlev A.; Kaplan R.; Lee S.H.; Kim S.-W.; Kim S.-I.; Kim W.J.; Antela Lopez A.; Casado Osorio J.L.; Castaño Carracedo M.A.; De Los Santos Gil I.; Estrada Perez V.; Falco Ferrer V.; Force L.; Galinda Puerto M.J.; Garcia Deltoro M.; Gatell J.M.; Goenaga Sanchez M.A.; González Cordón A.; Knobel H.; Lopez Bernaldo de Quiros J.C.; Losa Garcia J.E.; Masia M.; Montero-Alsonso M.; Ocampo Hermida A.; Pasquau Liaño J.; Portilla Sogorb J.; Pulido Ortega F.; Rivera Roman A.; Santos Fernandez J.R.; Torres Perea R.; Troya Garcia J.; Viciana Fernandez P.; Calmy A.; Hauser C.; Fehr J.; Cheng S.-H.; Ko W.-C.; Lin H.-H.; Lu P.-L.; Tseng Y.-T.; Wang N.-C.; Wong W.-W.; Yang C.-J.; Arduino R.; Benson P.; Berhe M.; Bredeek F.; Brinson C.; Campbell T.; Crofoot G.; Cunningham D.; DeJesus E.; Dretler R.; Eron J.; Fife K.; Fichtenbaum C.; Flamm J.; Goldstein D.; Gupta S.; Hagins D.; Hoffman-Terry M.; Jayaweera D.; Kinder C.; Klein D.; McDonald C.; Mills A.; Nahass R.; Osiyemi O.; Overton E.; Parks D.; Prelutsky D.; Ramgopal M.; Schrader S.; Sha B.; Simon G.; Sims J.; Skiest D.; Slim J.; Tashima K.; Thedinger B.; Gazzard B.; Fox J.; Johnson M.; Kegg S.; Khoo S.; Mazhude C.; Orkin C.; Schembri G.; Ustianowski A.; GEMINI Study Team | The Lancet | 252 | 238 | |
2021 | Dual therapy with dolutegravir plus boosted protease inhibitor as maintenance or salvage therapy in highly experienced people living with HIV | Lee Y.-L.; KUAN-YIN LIN ; Cheng S.-H.; Lu P.-L.; Wang N.-C.; Ho M.-W.; Yang C.-J.; Liou B.-H.; Tang H.-J.; Huang S.-S.; Huang S.-H.; Chen T.-C.; Lin C.-Y.; Lin S.-P.; Lee Y.-T.; CHIEN-CHING HUNG ; Taiwan HIV Study Group | International Journal of Antimicrobial Agents | 2 | 0 | |
2019 | Early Seroreversion After 2 Doses of Hepatitis A Vaccination in Human Immunodeficiency Virus–Positive Patients: Incidence and Associated Factors | Huang S.-H.; Huang C.-H.; Wang N.-C.; Chen T.-C.; Lee Y.-T.; Lin S.-P.; Lin T.-Y.; Lin C.-Y.; Lee Y.-L.; Lee C.-H.; Chen C.-P.; KUAN-YIN LIN ; Chen G.-J.; Liu C.-E.; Cheng S.-H.; Lu P.-L.; Yang C.-J.; CHIEN-CHING HUNG ; on behalf of the Taiwan HIV Study Group | Hepatology | 17 | 15 | |
2021 | Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide as Maintenance Treatment in HIV/HBV-Coinfected Patients | YU-SHAN HUANG ; Cheng C.-Y.; Liou B.-H.; Lu P.-L.; Cheng S.-H.; Lee Y.-T.; Liu C.-E.; HSIN-YUN SUN ; Yang C.-J.; Tang H.-J.; Lin S.-P.; Ho M.-W.; Huang S.-H.; Tsai H.-C.; Lee C.-H.; CHIEN-CHING HUNG ; Taiwan HIV Study Group | Journal of acquired immune deficiency syndromes (1999) | 10 | 9 | |
2015 | Emergence of OXA-48-producing Klebsiella pneumoniae in Taiwan | Ma L.; JANN-TAY WANG ; Wu T.-L.; Siu L.K.; Chuang Y.-C.; Lin J.-C.; Lu M.-C.; Lu P.-L. | PLoS ONE | 49 | 43 | |
2012 | Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) | Lu P.-L.; Liu Y.-C.; Toh H.-S.; Lee Y.-L.; Liu Y.-M.; Ho C.-M.; Huang C.-C.; Liu C.-E.; Ko W.-C.; Wang J.-H.; Tang H.-J.; Yu K.-W.; Chen Y.-S.; Chuang Y.-C.; Xu Y.; Ni Y.; Chen Y.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 151 | 135 | |
2017 | Epidemiology and Predictors of NTM Pulmonary Infection in Taiwan - A Retrospective, Five-Year Multicenter Study | Huang H.-L.; Cheng M.-H.; Lu P.-L.; CHIN-CHUNG SHU ; JANN-YUAN WANG ; JANN-TAY WANG ; Chong I.-W.; LI-NA LEE | Scientific Reports | 59 | 52 | |
2021 | The epidemiology, genotypes, antifungal susceptibility of Trichosporon species, and the impact of voriconazole on Trichosporon fungemia patients | Kuo S.-H.; Lu P.-L.; YEE-CHUN CHEN ; Ho M.-W.; Lee C.-H.; Chou C.-H.; Lin S.-Y. | Journal of the Formosan Medical Association | 11 | 9 | |
2014 | First report of blaIMP-8 in raoultella planticola | Tseng S.-P.; JANN-TAY WANG ; Liang C.-Y.; Lee P.-S.; YEE-CHUN CHEN ; Lu P.-L. | Antimicrobial Agents and Chemotherapy | 43 | 41 | |
2012 | Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents | Chen T.-C.; Chen Y.-H.; YEE-CHUN CHEN ; Lu P.-L. | Kaohsiung Journal of Medical Sciences | 20 | 18 | |
2003 | High-level expression of AmpC β-lactamase due to insertion of nucleotides between -10 and -35 promoter sequences in Escherichia coli clinical isolates: Cases not responsive to extended-spectrum-cephalosporin treatment | Siu L.K.; Lu P.-L.; Chen J.-Y.; Lin F.M.; SHAN-CHWEN CHANG | Antimicrobial Agents and Chemotherapy | 55 | 43 | |
2012 | Impact of revised CLSI breakpoints for susceptibility to third-generation cephalosporins and carbapenems among Enterobacteriaceae isolates in the Asia-Pacific region: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2002-2010 | Huang C.-C.; Chen Y.-S.; Toh H.-S.; Lee Y.-L.; Liu Y.-M.; Ho C.-M.; Lu P.-L.; Liu C.-E.; Chen Y.-H.; Wang J.-H.; Tang H.-J.; Yu K.-W.; Liu Y.-C.; Chuang Y.-C.; Xu Y.; Ni Y.; Ko W.-C.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 39 | 33 | |
2014 | Impacts of a mass vaccination campaign against pandemic H1N1 2009 influenza in Taiwan: A time-series regression analysis | UN-IN WU ; JANN-TAY WANG ; SHAN-CHWEN CHANG ; YU-CHUNG CHUANG ; Lin W.-R.; Lu M.-C.; Lu P.-L.; Hu F.-C.; Chuang J.-H.; YEE-CHUN CHEN ; SZU-MIN HSIEH ; Chien S.-F.; Chang H.-H.; Chang Y.-Y.; Lin H.-C.; Hong M.-C. | International Journal of Infectious Diseases | 16 | 14 | |
2018 | In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: Results from the 2017 surveillance of multicenter antimicrobial resistance in Taiwan (SMART) | Jean S.-S.; Lu M.-C.; Shi Z.-Y.; Tseng S.-H.; Wu T.-S.; Lu P.-L.; PEI-LAN SHAO ; Ko W.-C.; Wang F.-D.; PO-REN HSUEH | Infection and Drug Resistance | 34 | 34 | |
2012 | In vitro susceptibilities of non-Enterobacteriaceae isolates from patients with intra-abdominal infections in the Asia-Pacific region from 2003 to 2010: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) | Liu Y.-M.; Chen Y.-S.; Toh H.-S.; Huang C.-C.; Lee Y.-L.; Ho C.-M.; Lu P.-L.; Ko W.-C.; Chen Y.-H.; Wang J.-H.; Tang H.-J.; Yu K.-W.; Liu Y.-C.; Chuang Y.-C.; Xu Y.; Ni Y.; Liu C.-E.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 34 | 26 | |
2008 | In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan | Liu J.-W.; Wang L.-S.; Cheng Y.-J.; Hsu G.-J.; Lu P.-L.; Liu Y.-C.; Chen C.-M.; Lee C.-M.; Sun W.; Jang T.-N.; Chiang P.-C.; Chuang Y.-C.; Lin H.-C.; Shi Z.-Y.; HSIANG-CHI KUNG ; Huang C.-H.; Tsao S.-M.; Lu C.-T.; Liao C.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 16 | 17 | |
2008 | In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods | Liao C.-H.; HSIANG-CHI KUNG ; Hsu G.-J.; Lu P.-L.; Liu Y.-C.; Chen C.-M.; Lee C.-M.; Sun W.; Jang T.-N.; Chiang P.-C.; Cheng Y.-J.; Lin H.-C.; Shi Z.-Y.; Wang L.-S.; Chuang Y.-C.; Tsao S.-M.; Lu C.-T.; Liu J.-W.; Huang C.-H.; PO-REN HSUEH | International Journal of Antimicrobial Agents | 16 | 13 | |
2015 | Incidence and species distribution of candidaemia in Asia: A laboratory-based surveillance study | Tan B.H.; Chakrabarti A.; Li R.Y.; Patel A.K.; Watcharananan S.P.; Liu Z.; Chindamporn A.; Tan A.L.; Sun P.-L.; UN-IN WU ; YEE-CHUN CHEN ; Xu Y.-C.; Wang H.; Sun Z.-Y.; Wang L.-L.; Lu J.; Yang Q.; Zhang Q.-Q.; Shao H.F.; Liao K.; Woo P.C.Y.; Marak R.S.K.; Kindo A.J.; Wu C.-L.; Ho M.-W.; Lu P.-L.; Wang L.-S.; Riengchan P.; on behalf of the Asia Fungal Working Group (AFWG) | Clinical Microbiology and Infection | 120 | 110 | |
2000 | Infective endocarditis complicated with progressive heart failure due to β-lactamase-producing Cardiobacterium hominis | Lu P.-L.; PO-REN HSUEH ; CHIEN-CHING HUNG ; LEE-JENE TENG ; Jang T.-N.; KWEN-TAY LUH | Journal of Clinical Microbiology | 31 | 25 | |